Movement Alert｜Moderna, Inc. Intraday Rise 3.05% in Regular Trading, Cancer Vaccine Commercialization Expectations and Sector Strength Support Shares

Market Focus

Oct 15

On October 15, Moderna, Inc. rose 3.05% in Regular Trading, trading at $223.17 per share, with turnover of $18.6 billion.

The move came as the market continued to digest strengthening commercialization expectations for personalized cancer vaccine intismeran autogene, while biotechnology peers also advanced, reinforcing sector sentiment.

Recent developments show Moderna, Inc. expanded its collaboration with Merck and Tempus to support the potential commercialization of intismeran autogene, including tumor tissue and blood sample handling, sequencing, and manufacturing support. In parallel, a public-private initiative involving the US National Institutes of Health to accelerate cancer vaccine development has continued to bolster expectations for the mRNA oncology platform. The latest gain also aligns with broader strength across large biotechnology names, including AbbVie, Amgen, Vertex Pharmaceuticals, Gilead Sciences, and Regeneron Pharmaceuticals.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1166428589"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1166428589\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1166428589?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-10-15 01:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1166428589","market":"us","top_or_hot":-1,"title":"Movement Alert｜Moderna, Inc. Intraday Rise 3.05% in Regular Trading, Cancer Vaccine Commercialization Expectations and Sector Strength Support Shares","media":"Market Focus","content":"<p><p>On October 15, Moderna, Inc. rose 3.05% in Regular Trading, trading at $223.17 per share, with turnover of $18.6 billion.</p><p>The move came as the market continued to digest strengthening commercialization expectations for personalized cancer vaccine intismeran autogene, while biotechnology peers also advanced, reinforcing sector sentiment.</p><p>Recent developments show Moderna, Inc. expanded its collaboration with Merck and Tempus to support the potential commercialization of intismeran autogene, including tumor tissue and blood sample handling, sequencing, and manufacturing support. In parallel, a public-private initiative involving the US National Institutes of Health to accelerate cancer vaccine development has continued to bolster expectations for the mRNA oncology platform. The latest gain also aligns with broader strength across large biotechnology names, including AbbVie, Amgen, Vertex Pharmaceuticals, Gilead Sciences, and Regeneron Pharmaceuticals.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Moderna, Inc. Intraday Rise 3.05% in Regular Trading, Cancer Vaccine Commercialization Expectations and Sector Strength Support Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Moderna, Inc. Intraday Rise 3.05% in Regular Trading, Cancer Vaccine Commercialization Expectations and Sector Strength Support Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-10-15 01:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On October 15, Moderna, Inc. rose 3.05% in Regular Trading, trading at $223.17 per share, with turnover of $18.6 billion.</p><p>The move came as the market continued to digest strengthening commercialization expectations for personalized cancer vaccine intismeran autogene, while biotechnology peers also advanced, reinforcing sector sentiment.</p><p>Recent developments show Moderna, Inc. expanded its collaboration with Merck and Tempus to support the potential commercialization of intismeran autogene, including tumor tissue and blood sample handling, sequencing, and manufacturing support. In parallel, a public-private initiative involving the US National Institutes of Health to accelerate cancer vaccine development has continued to bolster expectations for the mRNA oncology platform. The latest gain also aligns with broader strength across large biotechnology names, including AbbVie, Amgen, Vertex Pharmaceuticals, Gilead Sciences, and Regeneron Pharmaceuticals.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MRNA","symbol_name":"Moderna, Inc.","start_time":0,"source_url":"","article_id":"1166428589","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1166428589","pubTimestamp":1791997271,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On October 15, Moderna, Inc. rose 3.05% in Regular Trading, trading at $223.17 per share, with turnover of $18.6 billion.The move came as the market continued to digest strengthening...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MRNA":"Moderna, Inc."},"translate_title":"走势警报|Moderna, Inc. 常规交易盘中上涨 3.05%，癌症疫苗商业化预期和行业强势支撑股价","themeId":null,"isJumpTheme":false,"ttsUrl":"https://static.tigerbbs.com/aa4a978466045cdfa3d25745ce7f7b44","symbols_score_info":{"MRNA":1},"content_text":"On October 15, Moderna, Inc. rose 3.05% in Regular Trading, trading at $223.17 per share, with turnover of $18.6 billion.The move came as the market continued to digest strengthening commercialization expectations for personalized cancer vaccine intismeran autogene, while biotechnology peers also advanced, reinforcing sector sentiment.Recent developments show Moderna, Inc. expanded its collaboration with Merck and Tempus to support the potential commercialization of intismeran autogene, including tumor tissue and blood sample handling, sequencing, and manufacturing support. In parallel, a public-private initiative involving the US National Institutes of Health to accelerate cancer vaccine development has continued to bolster expectations for the mRNA oncology platform. The latest gain also aligns with broader strength across large biotechnology names, including AbbVie, Amgen, Vertex Pharmaceuticals, Gilead Sciences, and Regeneron Pharmaceuticals.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}